Hi,
I did attend the AGM. In very brief – personally I feel the co has been doing great work and has good molecules in pipeline. The USFDA had done the inspections for both API and formulation plant and there were some observations (considered minor in their opinion) and the company has given the necessary responses and done the corrective actions…the final response is awaited. This is the critical milestone for the next phase of growth of the company. Its seems there might not be growth triggers for an year or two but after that the company may do well.
Regards,
Ayush
Disc: I’m invested
| Subscribe To Our Free Newsletter |
